When Heart Failure Treatment Isn’t Enough: Signs It’s Time to Refer for Advanced Heart Failure Care

• by

• August 28, 2026

Circulating Dipeptidyl Peptidase 3 levels, an Antagonist of Angiotensin-(1–7), in Acute Heart Failure: Insights from the PUSH-AHF trial

• by Stijn Legtenberg, Karine Santos, Iris E. Beldhuis, Oliver Hartmann, Lara E.E.C. Zonneveld, Peter van der Meer, Jan A. Krikken, Wybe Nieuwland, Dirk J. van Veldhuisen, Adriaan A. Voors, Kevin Damman, Jozine M. ter Maaten

• September 4, 2026

Simultaneous Versus Interval Sleeve Gastrectomy on Patients Requiring Left Ventricular Assist Devices for End-stage Heart Failure: A Retrospective, Single-Center Cohort Study

• by Oscar Olavarria, Syed Naqvi, Luke Crawford, Melissa Felinski, Shinil Shah, Peter Walker, Marwan Jumean, Manish Patel, Ismael Salas, Jayeshkumar Patel, Kha Dinh, Sriram Nathan, Bindu Akkanti, Biswajit Kar, Igor Gregoric, Kulvinder Bajwa

• September 22, 2026

Female patients less likely to receive invasive care

Review identifies recurring sex-based differences across specialties, including lower use of intensive and guideline-compliant treatment among female patients.

• by Andrea Surnit

• September 23, 2026

• 5 min